MedPath

A Trial intended to study the role of sentinel node biopsy technique in women with breast cancer who have had prior surgery for a breast lump

Not Applicable
Completed
Conditions
Health Condition 1: null- Breast cancer patients-post lumpectomy
Registration Number
CTRI/2014/08/004920
Lead Sponsor
Regional Cancer Centre Trivandrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1)pT1,T2 tumours (based on the pathology report)

2)N0 breast cancers(clinically and radiologically)

3)Invasive breast adenocarcinoma

Exclusion Criteria

1)Prior axillary surgery/Non oncologic breast surgery/ biopsies other than excision or lumpectomy/surgery to the ipsilateral breast prior to 3 months

2)Prior irradiation to the breast or axilla

3)Performance status ECOG 3,4

4)Pregnant and lactating women

5)Neoadjuvant Chemotherapy

6)Known Allergy to Human serum Albumin , Isosulfan Blue

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To validate the efficacy of the sentinel node biopsy technique in post lumpectomy breast cancer patients in terms of <br/ ><br>Identification rate <br/ ><br>False negative rateTimepoint: To validate the efficacy of the sentinel node biopsy technique in post lumpectomy breast cancer patients in terms of <br/ ><br>Identification rate <br/ ><br>False negative rate
Secondary Outcome Measures
NameTimeMethod
To determine sensitivity ,specificity ,positive and negative predictive value of the technique by comparison to axillary dissectionTimepoint: 2 years
© Copyright 2025. All Rights Reserved by MedPath